Get the Stockscreener App
0.00
100.00%
-5.67
Scpharmaceuticals Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.
See More
Previous Close:
$5.67
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$304.36M
Revenue:
$17.63M
Net Income/Loss:
$-57.71M
P/E Ratio:
0.00
EPS:
-1.48
Net Cash Flow:
$-60.45M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$6.2799
Scpharmaceuticals Inc Stock (SCPH) Company Profile
Name
Scpharmaceuticals Inc
Sector
Industry
Phone
617-517-0730
Address
25 BURLINGTON MALL ROAD, SUITE 203, BURLINGTON, MA
Compare SCPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SCPH
Scpharmaceuticals Inc
|
0.00 | 304.36M | 17.63M | -57.71M | -60.45M | -1.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Scpharmaceuticals Inc Stock (SCPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-07-23 | Initiated | Craig Hallum | Buy |
| Dec-01-22 | Initiated | Cowen | Outperform |
| Oct-21-22 | Resumed | Jefferies | Buy |
| Oct-11-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Aug-02-22 | Initiated | Maxim Group | Buy |
| Sep-09-21 | Initiated | SVB Leerink | Mkt Perform |
| Oct-15-19 | Initiated | H.C. Wainwright | Buy |
| Jan-30-19 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
View All
Scpharmaceuticals Inc Stock (SCPH) Latest News
What drives scPharmaceuticals Inc stock priceHigh Beta Stocks & Small Entry Portfolio - earlytimes.in
Is scPharmaceuticals Inc. (2SX) stock testing key supportWeekly Earnings Recap & Fast Exit/Entry Strategy Plans - Newser
Can scPharmaceuticals Inc. (2SX) stock resist broad market declinesJuly 2025 Fed Impact & AI Driven Price Forecasts - Newser
Will scPharmaceuticals Inc. (2SX) stock issue positive guidanceJuly 2025 Fed Impact & High Conviction Investment Ideas - Newser
Why scPharmaceuticals Inc. (2SX) stock attracts wealthy investorsJuly 2025 Patterns & Weekly Top Gainers Trade List - Newser
Is scPharmaceuticals Inc. (2SX) stock undervalued after correction2025 Price Targets & Risk Controlled Daily Plans - Newser
Will scPharmaceuticals Inc. (2SX) stock announce a stock split2025 Risk Factors & Weekly Watchlist for Consistent Profits - Newser
How scPharmaceuticals Inc. (2SX) stock trades after rate cuts2025 Winners & Losers & Technical Entry and Exit Tips - Newser
Will scPharmaceuticals Inc. (2SX) stock draw ESG focused fundsJuly 2025 Update & Consistent Return Strategy Ideas - Newser
Is scPharmaceuticals Inc. stock a contrarian buyPortfolio Value Report & Weekly High Conviction Trade Ideas - BỘ NỘI VỤ
scPharmaceuticals Inc 2SX Stock Analysis and ForecastSupport and Resistance Levels & Fast Profit Trading Ideas - earlytimes.in
Published on: 2025-11-21 07:32:18 - newser.com
Is scPharmaceuticals Inc. stock recession proofMarket Volume Report & Free Community Consensus Stock Picks - newser.com
Can scPharmaceuticals Inc. (2SX) stock beat analyst consensus2025 Price Action Summary & Consistent Profit Focused Trading Strategies - newser.com
Published on: 2025-11-20 01:49:28 - newser.com
Published on: 2025-11-20 00:39:07 - newser.com
Can scPharmaceuticals Inc. (2SX) stock hold up in economic slowdownJuly 2025 Macro Moves & Weekly High Return Opportunities - newser.com
Is scPharmaceuticals Inc. stock positioned for digital transformation2025 Trade Ideas & Scalable Portfolio Growth Ideas - newser.com
How rising interest rates impact scPharmaceuticals Inc. stockTrade Ideas & Fast Moving Market Watchlists - newser.com
Applying big data sentiment scoring on scPharmaceuticals Inc.Volume Spike & Precise Buy Zone Identification - newser.com
Why scPharmaceuticals Inc. (2SX) stock stays on buy listsLong Setup & Daily Volume Surge Trade Alerts - newser.com
Will scPharmaceuticals Inc. stock deliver consistent dividendsMarket Trend Summary & AI Forecast Swing Trade Picks - newser.com
Measuring scPharmaceuticals Inc.’s beta against major indicesQuarterly Market Review & Daily Price Action Insights - newser.com
Published on: 2025-11-19 05:13:42 - newser.com
Using data models to predict scPharmaceuticals Inc. stock movementQuarterly Trade Report & Breakout Confirmation Alerts - newser.com
What insider trading reveals about scPharmaceuticals Inc. stockShort Setup & Real-Time Volume Triggers - newser.com
How to integrate scPharmaceuticals Inc. into portfolio analysis toolsIPO Watch & Daily Profit Maximizing Tips - newser.com
Scpharmaceuticals Inc Stock (SCPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):